Cookies on VetMed Resource

Like most websites we use cookies. This is to ensure that we give you the best experience possible.

 

Continuing to use www.cabi.org  means you agree to our use of cookies. If you would like to, you can learn more about the cookies we use.

VetMed Resource

Veterinary information to support practice, based on evidence and continuing education

Sign up to receive our Veterinary & Animal Sciences e-newsletter, book alerts and offers direct to your inbox.

Results per page:

Search results

Abstract

Background: Lowering the cosyntropin dose needed for ACTH stimulation would make the test more economical. Objectives: To compare the cortisol response to 1 and 5 µg/kg cosyntropin IV in dogs being screened for hyperadrenocorticism (HAC) and in dogs receiving trilostane or mitotane for...

Author(s)
Aldridge, C.; Behrend, E. N.; Kemppainen, R. J.; Lee-Fowler, T. M.; Martin, L. G.; Ward, C. R.; Bruyette, D.; Pannu, J.; Gaillard, P.; Lee, H. P.
Publisher
Wiley-Blackwell, Boston, USA
Citation
Journal of Veterinary Internal Medicine, 2016, 30, 5, pp 1637-1641
Abstract

Background: Maximal aldosterone secretion in healthy dogs occurs 30 minutes postadrenocorticotropin (ACTH; 5 µg/kg IV) stimulation. The effect of trilostane and mitotane on aldosterone at that time is unknown. Objectives: To assess the effect of trilostane and mitotane in dogs with...

Author(s)
Reid, L. E.; Behrend, E. N.; Martin, L. G.; Kemppainen, R. J.; Ward, C. R.; Lurye, J. C.; Donovan, T. C.; Lee, H. P.
Publisher
Wiley-Blackwell, Boston, USA
Citation
Journal of Veterinary Internal Medicine, 2014, 28, 2, pp 443-450
Abstract

Background: Treatment of adrenal-dependent hyperadrenocorticism (ADH) involves either surgical resection of the adrenal tumor or medical therapy. For many years, mitotane has been considered the medical treatment of choice for dogs with ADH. Objectives: The aim of this study was to determine...

Author(s)
Arenas, C.; Melián, C.; Pérez-Alenza, M. D.
Publisher
Wiley-Blackwell, Boston, USA
Citation
Journal of Veterinary Internal Medicine, 2014, 28, 2, pp 473-480
AbstractFull Text

A 5-year-old, Terrier breed dog having the complaints of anestrus, polyuria, polydipsia and alopecia referred to Small Animal Veterinary Teaching Hospital. Paraclinical and clinical assessments confirmed the diagnosis of pituitary-dependent hyperadrenocorticism and Mitotane (25 mg/kg BID 5 days)...

Author(s)
Çolakoğlu, E. Ç.; Haydardedeoğlu, A. E.; Alİhosseİnİ, H.; Kurtdede, A.
Publisher
Kafkas Üniversitesi, Veteriner Fakültesi Dergisi, Kars, Turkey
Citation
Kafkas Üniversitesi Veteriner Fakültesi Dergisi, 2015, 21, 1, pp 135-137
Abstract

A retrospective study was conducted to determine the factors that might influence the survival in dogs with adrenal-dependent hyperadrenocorticism (ADH) medically managed with either trilostane or mitotane. Clinical data were analysed for all dogs with ADH diagnosed at 4 participating referral...

Publisher
Advanstar Communications Inc, Duluth, USA
Citation
Veterinary Medicine, 2011, 106, 7, pp 328-329
Abstract

Objective - To evaluate the effects of mitotane administration on the function and morphology of pituitary corticotrophs in clinically normal dogs. Animals - 12 clinically normal adult Beagles. Procedures - Dogs were randomly assigned to the control group or the mitotane treatment group. In ...

Author(s)
Taoda, T.; Hara, Y.; Takekoshi, S.; Itoh, J.; Teramoto, A.; Osamura, R. Y.; Tagawa, M.
Publisher
American Veterinary Medical Association, Schaumburg, USA
Citation
American Journal of Veterinary Research, 2006, 67, 8, pp 1385-1394
Abstract

OBJECTIVE: To evaluate clinical signs, endocrine test results, and pituitary tumor size for dogs with medically managed pituitary-dependent hyperadrenocorticism (PDH) and macroadenoma following 6 months of concurrent treatment with pasireotide. DESIGN: Prospective case series. ANIMALS: 9...

Author(s)
Lottati, M.; Bruyette, D. S.
Publisher
American Veterinary Medical Association, Schaumburg, USA
Citation
Journal of the American Veterinary Medical Association, 2018, 252, 11, pp 1403-1408
Abstract

We report a case of pituitary-dependent hyperadrenocorticism in a 10-year-old, female, terrier dog. The animal was admitted due to polyphagia, weight gain, polyuria, polydipsia, hair loss, exercise intolerance and panting at rest. On physical examination, abdominal distention, truncal and...

Author(s)
Rezaei, M.; Rostami, S.; Saberi, M.; Vosugh, D.
Publisher
Journal of Coastal Life Medicine, Haikou, China
Citation
Journal of Coastal Life Medicine, 2016, 4, 6, pp 502-504
Abstract

Background: Trilostane is a recognized treatment for canine pituitary-dependent hyperadrenocorticism (PDH); however, its efficacy in dogs with adrenal-dependent hyperadrenocorticism (ADH) is unknown. Objectives: To examine factors that might influence survival in the medical management of ADH, with ...

Author(s)
Helm, J. R.; McLauchlan, G.; Boden, L. A.; Frowde, P. E.; Collings, A. J.; Tebb, A. J.; Elwood, C. M.; Herrtage, M. E.; Parkin, T. D. H.; Ramsey, I. K.
Publisher
Wiley-Blackwell, Boston, USA
Citation
Journal of Veterinary Internal Medicine, 2011, 25, 2, pp 251-260
Abstract

Hypoadrenocorticism (HOAC; Addison's disease) is an endocrine condition seen in small animal practice. Dogs with this disease can present in a variety of ways from acute hypovolemic collapse to vague, chronic, waxing, and waning clinical signs. In the most common form of this disease, animals have...

Author(s)
Lathan, P.; Thompson, A. L.
Publisher
Dove Medical Press Ltd, Macclesfield, UK
Citation
Veterinary Medicine: Research and Reports, 2018, 9, pp 1-10

Refine Results

Sort Order
Author
Geographical Location
Item Type
Language
Organisms
Subject Topics